Ani Pharmaceuticals (ANIP) Gross Profit Growth (3y) (2015 - 2026)
Ani Pharmaceuticals (ANIP) Gross Profit Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.87 Bn | 42.91 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.00 Bn | 39.35 Bn | 2.15 Bn | 6.23% |
| 3 | Zoetis | 31.59 Bn | 29.92 Bn | 1.05 Bn | 3.42% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -0.01% |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | 8.70% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -3.26% |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 28.48% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 8.60% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn | 30.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30.72% |
| Mar 31, 2026 | 27.71% |
| Dec 31, 2025 | 36.35% |
| Sep 30, 2025 | 38.20% |
| Jun 30, 2025 | 52.50% |
| Mar 31, 2025 | 60.16% |
| Dec 31, 2024 | 59.80% |
| Sep 30, 2024 | 45.55% |
| Jun 30, 2024 | 45.08% |
| Mar 31, 2024 | 129.25% |
| Dec 31, 2023 | 33.73% |
| Sep 30, 2023 | 36.58% |
| Jun 30, 2023 | 38.79% |
| Mar 31, 2023 | 35.17% |
| Dec 31, 2022 | 24.27% |
| Sep 30, 2022 | 11.91% |
| Jun 30, 2022 | -0.14% |
| Mar 31, 2022 | -7.50% |
| Dec 31, 2021 | -9.93% |
| Sep 30, 2021 | -7.64% |